AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter MV 1mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimter MV 1mg/500mg/0.3mg Tablet SR

Diabetic patients using Glimter MV 1mg/500mg/0.3mg SR tablets, an anti-diabetic combination medication, should adhere to their physician's prescribed dosage and timing for optimal blood sugar management. This medication, taken with meals consistently, aids in controlling type 2 diabetes in adults. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potential complications like kidney damage, vision impairment, neuropathy, and limb loss. This medicine complements a comprehensive treatment plan including diet, exercise, and weight management as directed by a healthcare professional. Hypoglycemia (low blood sugar), a common side effect, manifests as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Consult your doctor before using Glimter MV if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood sugar monitoring, along with periodic blood cell and liver function tests, is necessary.

Uses of Glimter MV 1mg/500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimter MV 1mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Glimter MV 1mg/500mg/0.3mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet on an empty stomach.

Common Side effects of Glimter MV 1mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimter MV 1mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MV 1mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.

How Glimter MV 1mg/500mg/0.3mg Tablet SR works:

Glimter MV extended-release tablets (1mg/500mg/0.3mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimter MV 1mg/500mg/0.3mg Tablet SR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimter MV 1mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimter MV 1mg/500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimter MV 1mg/500mg/0.3mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimter MV 1mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. In individuals with mild to moderate liver disease, initiate treatment with a low dose of Glimter MV 1mg/500mg/0.3mg SR tablets; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimter MV 1mg/500mg/0.3mg Tablet SR :

Should you forget to take a Glimter MV 1mg/500mg/0.3mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimter MV 1mg/500mg/0.3mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimter MV 1mg/500mg/0.3mg Tablet SR

Glimter MV 1mg/500mg/0.3mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing glycemic control when coupled with a suitable diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar levels. This combination therapy is unsuitable for type 1 diabetes.
Glimter MV 1mg/500mg/0.3mg SR tablets may cause common adverse events including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory infections.
Patients with hypersensitivity to Glimter MV 1mg/500mg/0.3mg Tablet SR's constituents or inactive ingredients should not use this medication. Similarly, its administration is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Glimter MV 1mg/500mg/0.3mg SR tablets with alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimter MV 1mg/500mg/0.3mg SR tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. These symptoms are exacerbated by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Glimter MV 1mg/500mg/0.3m...
94
MRP 115
18% off